Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sam S Chang

Showing results (481-490 of 490) with videos related to

Pageof 49
Sort By:
You have reached the last page of results.This site can display upto 490 results.
Journal of the National Comprehensive Cancer Network : JNCCN|February 19, 2015
Kidney cancer, version 3.2015Robert J Motzer, Eric Jonasch, Neeraj Agarwal, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|March 4, 2014
Kidney cancer, version 2.2014Robert J Motzer, Eric Jonasch, Neeraj Agarwal, et al.
Lancet (London, England)|July 7, 2018
Robot-assisted radical cystectomy versus open radical cystectomy in patients with bladder cancer (RAZOR): an open-label, randomised, phase 3, non-inferiority trialDipen J Parekh, Isildinha M Reis, Erik P Castle, et al.
The Journal of Urology|September 25, 2019
Predictors of Recurrence, and Progression-Free and Overall Survival following Open versus Robotic Radical Cystectomy: Analysis from the RAZOR Trial with a 3-Year FollowupVivek Venkatramani, Isildinha M Reis, Erik P Castle, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|May 16, 2024
NCCN Guidelines® Insights: Bladder Cancer, Version 3.2024Thomas W Flaig, Philippe E Spiess, Michael Abern, et al.
The Journal of Urology|October 9, 2024
Predicting Response to Intravesical Bacillus Calmette-Guérin in High-Risk Nonmuscle-Invasive Bladder Cancer Using an Artificial Intelligence-Powered Pathology Assay: Development and Validation in an International 12-Center CohortYair Lotan, Viswesh Krishna, Waleed M Abuzeid, et al.
The Journal of Urology|April 28, 2026
Non-Invasive Urine Test Predicts Grade Group Upgrading in Patients on Active Surveillance for Prostate Cancer: Multisite Validation and Comparison with MRIJeffrey J Tosoian, Jacob I Meyers, Bradley Moore, et al.
JAMA Network Open|October 2, 2023
Accuracy and Reliability of Chatbot Responses to Physician QuestionsRachel S Goodman, J Randall Patrinely, Cosby A Stone, et al.
The Journal of Urology|May 5, 2024
Efficacy of Intravesical Nadofaragene Firadenovec for Patients With Bacillus Calmette-Guérin-Unresponsive Nonmuscle-Invasive Bladder Cancer: 5-Year Follow-Up From a Phase 3 TrialVikram M Narayan, Stephen A Boorjian, Mehrdad Alemozaffar, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 15, 2025
Twelve-Month Results From the CISTO Study Comparing Radical Cystectomy Versus Bladder-Sparing Therapy for Recurrent High-Grade Non-Muscle-Invasive Bladder CancerJohn L Gore, Erika M Wolff, Michael G Nash, et al.
Pageof 49

Showing results (481-490 of 490) with videos related to

Sort By:
Pageof 49
You have reached the last page of results.This site can display upto 490 results.
Journal of the National Comprehensive Cancer Network : JNCCN|February 19, 2015
Kidney cancer, version 3.2015Robert J Motzer, Eric Jonasch, Neeraj Agarwal, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|March 4, 2014
Kidney cancer, version 2.2014Robert J Motzer, Eric Jonasch, Neeraj Agarwal, et al.
Lancet (London, England)|July 7, 2018
Robot-assisted radical cystectomy versus open radical cystectomy in patients with bladder cancer (RAZOR): an open-label, randomised, phase 3, non-inferiority trialDipen J Parekh, Isildinha M Reis, Erik P Castle, et al.
The Journal of Urology|September 25, 2019
Predictors of Recurrence, and Progression-Free and Overall Survival following Open versus Robotic Radical Cystectomy: Analysis from the RAZOR Trial with a 3-Year FollowupVivek Venkatramani, Isildinha M Reis, Erik P Castle, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|May 16, 2024
NCCN Guidelines® Insights: Bladder Cancer, Version 3.2024Thomas W Flaig, Philippe E Spiess, Michael Abern, et al.
The Journal of Urology|October 9, 2024
Predicting Response to Intravesical Bacillus Calmette-Guérin in High-Risk Nonmuscle-Invasive Bladder Cancer Using an Artificial Intelligence-Powered Pathology Assay: Development and Validation in an International 12-Center CohortYair Lotan, Viswesh Krishna, Waleed M Abuzeid, et al.
The Journal of Urology|April 28, 2026
Non-Invasive Urine Test Predicts Grade Group Upgrading in Patients on Active Surveillance for Prostate Cancer: Multisite Validation and Comparison with MRIJeffrey J Tosoian, Jacob I Meyers, Bradley Moore, et al.
JAMA Network Open|October 2, 2023
Accuracy and Reliability of Chatbot Responses to Physician QuestionsRachel S Goodman, J Randall Patrinely, Cosby A Stone, et al.
The Journal of Urology|May 5, 2024
Efficacy of Intravesical Nadofaragene Firadenovec for Patients With Bacillus Calmette-Guérin-Unresponsive Nonmuscle-Invasive Bladder Cancer: 5-Year Follow-Up From a Phase 3 TrialVikram M Narayan, Stephen A Boorjian, Mehrdad Alemozaffar, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 15, 2025
Twelve-Month Results From the CISTO Study Comparing Radical Cystectomy Versus Bladder-Sparing Therapy for Recurrent High-Grade Non-Muscle-Invasive Bladder CancerJohn L Gore, Erika M Wolff, Michael G Nash, et al.
Pageof 49